← Our writersGoal-guide writer
Molly Ward
Writes the goal pages for the reader deciding where to start, and keeps every step honest about what is known.
Molly Ward writes This Peptide's goal guides, the pages that start from what a reader wants to change rather than from a molecule. Her job is to turn what the evidence editor has sourced into a clear order of questions: what to ask a prescriber, what a realistic timeline looks like, and which options have human studies behind them and which do not. She does not recommend starting or stopping any medicine; that decision belongs to the reader and their prescriber. No clinical credentials are claimed here.
What they cover
- Weight management options and timelines
- Sleep and recovery goals
- Questions to ask a telehealth prescriber
- Reading a treatment plan
- Setting realistic expectations
Articles by Molly Ward
36 pieces- Ozempic Diarrhea: How Common It Is, How Long It Lasts and When to CallSafety
- Can Ozempic Cause Low Blood Sugar? Hypoglycemia Risk, Symptoms and Who Runs LowSafety
- Intermittent Fasting and GLP-1 Drugs: What the Guidance and Fasting Studies ShowEvidence
- Ozempic and Coffee: The Tablet's 30-Minute Rule and What the Pen Label SaysEvidence
- Wegovy for Teens: What the Label and the STEP TEENS Trial ShowEvidence
- Sulfur Burps on Ozempic and Zepbound: What the Labels CountSafety
- Corporate Practice of Medicine in Telehealth: Who Is Your Doctor?Safety
- Your Peptides Arrived Warm: What the Stability Studies MeasuredSafety
- AOD-9604: the rat study behind the fat-loss claimEvidence
- Peptides for Sex Drive: PT-141, Kisspeptin and Oxytocin in the TrialsEvidence
- What to Eat on Tirzepatide: What the Trials PrescribedEvidence
- Semaglutide for PCOS: What the Trials Have Actually MeasuredEvidence
- Semaglutide Insomnia: What the Labels and Sleep Studies RecordSafety
- Tirzepatide Plateau: When Weight Loss Slows in the TrialsEvidence
- Ozempic Nausea: How Common It Is, When It Fades and What HelpsSafety
- Tirzepatide Diarrhea: Trial Rates, Timing and the Steps Guidance ListsSafety
- Peptides for Anti-Aging: What Human Studies Show for Skin, Growth Hormone and NAD+Evidence
- Semaglutide Constipation: How Common It Is, How Long It Lasts, and What Guidance SuggestsSafety
- What to Eat on Semaglutide: The 2025 Nutrition Advisory, Protein and Side EffectsEvidence
- How Long Does It Take for Semaglutide to Work? What Happens Week by WeekEvidence
- Peptides for Energy: What Human Studies Actually MeasuredEvidence
- Liraglutide Side Effects: What Saxenda's Trials Recorded, Week by WeekSafety
- Peptides for Inflammation: Which Ones Have Human EvidenceEvidence
- Microdosing Semaglutide: What Low-Dose Trials Show, and What No Trial TestedEvidence
- Bremelanotide (PT-141): The FDA Approval and What the Trials ShowedEvidence
- Glutathione for Skin: What Trials of Oral, Topical and Injected Forms FoundEvidence
- NAD IV Therapy: What Studies of Intravenous NAD+ in People MeasuredEvidence
- Peptide Injection Sites: Where the Labels Say to InjectFormats
- Peptides for Hair Growth: What the Trials ShowEvidence
- Peptides for Joint Pain: What Human Trials Exist, Compound by CompoundEvidence
- Peptides for Muscle Growth: What Trials of GH Secretagogues MeasuredEvidence
- Peptides for Skin: Which Ones Have Human TrialsEvidence
- Peptides for Sleep: What Human Studies of GHRH and DSIP FoundEvidence
- Peptides for Weight Loss: What the Evidence Shows Beyond Semaglutide and TirzepatideEvidence
- Sermorelin Before and After: What Trials Measured Over Weeks and MonthsEvidence
- What Happens When You Stop Taking Semaglutide: The Trial Extension DataEvidence